Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced initial data from its Phase 2 study...
Read moreThe protein-based vaccine candidate NVX-CoV2373 is made from the genetic sequence of the first SARS-CoV-2 strain. It is adjuvanted with...
Read moreAnkyra Therapeutics, a biotechnology company developing cancer therapies based on localized cytokines that prime a systemic adaptive immune response, and...
Read moreLabConnect, Inc. and Cryoport, Inc. announced a partnership to provide comprehensive logistics support for an upcoming Phase I/II clinical trial...
Read moreRentschler Biopharma and Vetter, two globally operating Contract Development and Manufacturing Organizations (CDMOs), announced today that their strategic collaboration has...
Read moreLonza, a CDMO partner to the biopharma industry, announced the construction of a new small molecule manufacturing complex at its...
Read moreRecro Pharma, Inc. , a contract development and manufacturing organization dedicated to solving complex formulation and manufacturing challenges for companies...
Read moreCharles River Laboratories International, Inc. and Valence Discovery announced the formation of a strategic partnership to provide clients access to...
Read moreAB Science SA, together with the University of Chicago, announces the signing of an exclusive licensing agreement for conducting research...
Read moreEli Lilly and Company and Incyte announced results of COV-BARRIER, a Phase 3 study evaluating baricitinib 4 mg once daily...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.